Splicing mutations, mainly IVS6-1(G>T), account for 70% of fumarylacetoacetate hydrolase (FAH) gene alterations, including 7 novel mutations, in a survey of 29 tyrosinemia type I patients.

Source:http://linkedlifedata.com/resource/pubmed/id/12203990

Download in:

View as

General Info

PMID
12203990